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INTRODUCTION
Quality improvement (QI) is the continuous 
improvement of healthcare quality with a 
focus on patient-centred outcomes.1 QI 
is a priority for UK general practice as 
outlined in the NHS policy across all four 
devolved nations.2–5 Prescribing safety is 
an important focus for QI and current UK 
initiatives in this area using electronic health 
record (EHR) data are outlined in Box 1. The 
need for more research in this area has 
been highlighted.6 During the development 
of this project the authors were unable to 
find any initiatives that addressed all the 
following needs: benchmarking, individual 
case-finding, and scalability with minimal 
resource use to enable sustainability.
This article reports on the Royal College 
of General Practitioners’ (RCGP) QI pilot 
project that was jointly initiated in 2015 by 
the RCGP and Clinical Practice Research 
Datalink (CPRD), a government research 
service providing de-identified patient data 
for public health research (www.cprd.
com). The project explored the potential of 
using routinely collected primary care EHR 
data to support QI in general practice by 
providing confidential practice-level reports 
that would enable both benchmarking 
and individual case-finding with a focus 




GP practices in the UK contributing data 
to CPRD were invited to participate in the 
pilot via channels described in Figure 1 in 
August 2016.
Scoping phase
A scoping review and stakeholder 
interviews were conducted to identify 
existing examples of how routine data 
were used for QI in primary care and gaps 
in current provision. Semi-structured 
interviews (n = 17) were conducted with 
stakeholders including GPs, RCGP clinical 
advisers, public health researchers, and 
epidemiologists and representatives from 
the Medicines and Healthcare products 
Regulatory Agency (MHRA), NHS England, 
the Health Foundation, National Institute for 
Health Research (NIHR), National Institute 
for Health and Care Excellence (NICE), and 
the Health and Social Care Information 
Centre (HSCIC). 
Design phase
The design phase focused on developing a 
report that was useful, easy to interpret, and 
helpful in clinical practice. A sample report 
containing dummy data was developed and 
sent in two iterations to clinicians with 




Quality improvement (QI) is a priority for general 
practice, and GPs are expected to participate 
in and provide evidence of QI activity. There is 
growing interest in harnessing the potential 
of electronic health records (EHR) to improve 
patient care by supporting practices to find 
cases that could benefit from a medicines 
review.
Aim
To develop scalable and reproducible 
prescribing safety reports using patient-level 
EHR data.
Design and setting
UK general practices that contribute 
de-identified patient data to the Clinical 
Practice Research Datalink (CPRD). 
Method
A scoping phase used stakeholder 
consultations to identify primary care QI 
needs and potential indicators. QI reports 
containing real data were sent to 12 pilot 
practices that used Vision GP software and 
had expressed interest. The scale-up phase 
involved automating production and distribution 
of reports to all contributing practices that 
used both Vision and EMIS software systems. 
Benchmarking reports with patient-level case 
review lists for two prescribing safety indicators 
were sent to 457 practices in December 2017 
following the initial scale-up (Figure 2). 
Results
Two indicators were selected from the Royal 
College of General Practitioners Patient Safety 
Toolkit following stakeholder consultations 
for the pilot phase involving 12 GP practices. 
Pilot phase interviews showed that reports 
were used to review individual patient care, 
implement wider QI actions in the practice, and 
for appraisal and revalidation. 
Conclusion
Electronic health record data can be used to 
provide standardised, reproducible reports that 
can be delivered at scale with minimal resource 
requirements. These can be used in a national 
QI initiative that impacts directly on patient care.
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focused on data presentation, supporting 
information that could be included, and the 
format in which GPs would prefer to receive 
the report. Round 2 focused on the clinical 
indicators in the report, case definitions, 
and accompanying advice to maximise the 
utility and impact of the final reports.
Implementation phase 
After addressing feedback received in the 
design phase, QI reports containing real 
data were sent to 12 practices that used 
Vision GP software and had expressed 
interest in giving feedback on how the 
reports were used in practice.
Scale-up phase
The initial programming was extended 
to include multiple practices using 
either Vision or EMIS GP software and 
was tailored to enable feedback over 
different reporting periods. In addition, the 
production and dissemination of reports 
were automated to enable scale-up with 
minimal additional resource requirements. 
Manual validation was undertaken for a 
sample of the automated reports. Figure 1 
summarises the pilot study methodology 
and participation numbers for each phase. 
Benchmarking reports with patient-level 
case review lists for two prescribing safety 
indicators were sent to 457 practices in 
December 2017 following the initial scale-
up.
Data analysis
Stakeholder interviews and free text 
GP responses were analysed using 
thematic analysis.12 Descriptive statistics 
(percentages) to summarise online survey 
responses were obtained using the in-built 
statistical analysis feature in SurveyMonkey, 
which was used to administer the online 
surveys. Initial programming for the 
QI reports was undertaken using Stata 
(version 14), and SAS (version 9.4) was 
used for the automation of production and 
dissemination of reports. 
RESULTS
Scoping phase
The review identified existing primary 
care data reports from a range of sources 
(including national and regional bodies, and 
health analytic companies) covering topics 
that included service use metrics, referrals 
to secondary care, medicine prescribing 
and costs, and adherence to guidelines. A 
clear preference was expressed for a focus 
on prescribing safety in the 17 stakeholder 
interviews. Key gaps in QI reports available 
to GPs were: lack of information at a patient-
level, non-user-friendly formats, and 
regional differences in availability. Based 
on the findings of the review exercise and 
the stakeholder interviews, a set of general 
principles for guiding development of the 
reports was developed (Box 2). The RCGP/
CPRD QI project steering committee then 
agreed decision criteria to guide selection of 
safety indicators for inclusion in the reports 
(Box 3). 
Two indicators from the RCGP Patient 
Safety Toolkit relating to prescribing in 
patients with heart failure were selected for 
use in the pilot study: prescribing of non-
steroidal anti-inflammatory drugs (NSAIDs); 
and prescribing of thiazolidinediones 
(glitazones). Two case definitions were 
used to identify patients with heart failure 
using the Read code hierarchy: a narrow 
How this fits in
Several studies have explored the potential 
of using electronic health record data in 
regional quality improvement initiatives, 
but no single initiative has met all the 
following needs: benchmarking, individual 
case-finding, and scalability with minimal 
resource use to enable sustainability. 
The current project designed and piloted 
bespoke reports to allow benchmarking of 
practice-level prescribing safety indicators 
with individual case-finding. These reports 
are provided at no cost to GPs contributing 
to the Clinical Practice Research Datalink 
(CPRD) and aim to improve prescribing 
safety by offering standardised patient-level 
case-finding with minimal GP workload. 
The reports were scaled up to multiple GP 
software systems, and hence additional 
UK practices, and their production and 
dissemination automated, thus enabling 
repeat reporting using minimal resources. 
Box 1. QI initiatives in the UK with a focus on prescribing safety
•  Salford medication safety dashboard — software developed to sit on GP computers, allowing them to run 
reports identifying patients requiring review based on a number of prescribing indicators. Implemented in 
43 practices.7,8
•  PINCER tool — developed as part of a pharmacist-led trial to improve prescribing safety in the East 
Midlands. Software sits on GP computers and produces reports to identify patients at risk of common 
prescribing errors. NHS England is supporting wider roll-out.9 
•  Margham’s trigger tool — study conducted in one test practice with focus on GP evaluation of a prescribing 
safety trigger tool.10
•  EFIPPS trial — cluster randomised trial in 262 practices evaluating feedback on prescribing safety. 
Feedback included benchmarking of a practice’s prescribing rate against the 25% ‘best practices’ for each 
indicator. Advice was given on how to implement system searches for the individual patients.11
EFIPPS = Effective Feedback to Improve Primary Care Prescribing Safety trial. PINCER = pharmacist-led 
information technology intervention for medication errors. QI = quality improvement.
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one based on the Quality and Outcomes 
Framework (QOF) prevalence definition,13 
and a broad definition that included all 
relevant codes identified following a code 
review by the project team comprising 
epidemiologists, data experts, and GPs. 
Both heart failure definitions were included 
in the final report based on survey results. A 
sample report is available from the authors 
on request. 
Design phase
Survey responses were received from a total 
of 31 (round 1) and 21 (round 2) clinicians in 
response to the sample report containing 
dummy data. All survey responders fed 
back that the report was useful for their 
clinical practice. In terms of content, key 
elements identified as being useful were 
benchmarking of an individual practice’s 
prescribing rate against the other practices 
in the network and case-finding, which 
meant that reports could be used not just 
for peer comparison, but also directly for 
patient care by enabling individual patient 
review.
In round 1, most responders (n = 18, 58%) 
preferred bar charts over funnel or box plots 
for presentation of benchmarking data. 
The report template included a ‘what next’ 
section with more guidance on best practice 
for the topic of the data report. Subsections 
included ‘why this topic is important’, 
‘suggested actions’, ‘alternative treatment’, 
and ‘links to further resources’. Responders 
felt all subsections were relevant (n = 25, 
81%) and 18 (86%) of round 2 responders felt 
there was the ‘right amount of information’ 
in this section. The reports were felt to be 
‘about right’ in terms of length by most 
responders (n = 26, 84%) in round 1.
Review exercise.
Identify metrics available to GPs that may be used
for QI in primary care
Stakeholder interviews (n = 17).
To ensure the review exercise did not miss any
important metrics and to understand how the
RCGP/CPRD reports could add value
to what is available
First sample report. 
Containing hypothetical data.
Sent to 34 GPs who had responded to date
Second sample report. 
Containing hypothetical data. Updated in
light of survey 1 feedback.
Sent to 116 GPs who had responded to date
Pilot report.
Containing real data. Updated in
light of survey 2 feedback.
Sent to 12 GPs
Report sent to all CPRD practices (July 2017).
Containing real data. No changes made
as a result of GP interviews.
Sent to 291 practices
Report sent to all CPRD practices (December 2017)
Containing real data. Scaled up to work with
CPRD EMIS practices.
Sent to 457 practices
Practice recruitment for pilot
participation.
RCGP’s Clinical News newsletter,
Federations Network, and Chair’s blog;
QI Ready e-learning network;
Clinical Research Network
Research Ready programme,
direct contact with GPs via
CPRD and RCGP
Survey 1 sent to 34 practices.
Focus on data presentation.
31 GPs (97%) responded
Survey 2 sent to 116 practices.
Focus on the clinical indicators
and maximising impact.
21 GPs (18%) responded
Interviews conducted with three GPs.
Focus on how the reports were used
for QI
Figure 1. Flow diagram of study methodology. 
CPRD = Clinical Practice Research Datalink. 
QI = quality improvement. RCGP = Royal College of 
General Practitioners. 
Box 2. General principles for guiding development of QI reports based 
on scoping interviews
•  Do not overload GPs and practice staff with information.
•  Make reports directly relevant to improving patient care, ideally by allowing GPs to re-identify patients 
whose care may need to be reviewed.
•  Make it clear what GPs can do as a result of the report; the expected action must be clear and directly 
beneficial to patients.
•  Benchmarking, both at GP level within practices as well as at practice level across the whole dataset, 
would be a useful way of making GPs think about the care they provide; this overview would then provide 
users with the incentive to drill down to the patient level.
•  Any reports must not only be quick and easy to understand for all practice staff but also add value to make 
them worth taking time to read.
•  It is important not to present these reports as a performance management measure; the reports must be 
supportive of practice initiatives around quality improvement.
QI = quality improvement.
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In round 1 there was some variation 
in the preferred frequency of the reports, 
with 17 (55%) of responders suggesting 
quarterly reports would be best, whereas 
6 (19%) preferred 6-monthly reports and 
5 (16%) monthly reports. Most responders 
expressed a preference for pdf reports 
sent by email (n = 26, 84%), with 5 (16%) 
preferring to log in to an online portal 
or receive a pop-up notification in the 
practice system, and only 1 (3%) preferred 
a paper report sent by post. Figures 2 and 
3 show the benchmarking and case-finding 
elements of the reports, using hypothetical 
data.
Implementation phase 
Interviews were conducted with three GPs 
to discuss the utility of the reports. Use of 
the reports fell into three broad categories:
Individual patient review. For patients with 
heart failure who were identified as having 
been prescribed NSAIDs using the reports, 
the following actions were taken after 
review: no further action required for acute 
(one-off) prescriptions; repeat prescriptions 
for chronic pain were inactivated and 
meetings arranged with patients to 
discuss their ongoing pain management; 
patients moved to other pain medication; 
some patients decided that the benefits of 
NSAIDs outweighed the risks. In the last 
case, NSAID prescription continued but was 
altered to low-dose naproxen or ibuprofen:
‘I reviewed patients as a result of the report, 
then took it to the partner’s meeting. One 
patient (on NSAIDs) had a flag put on, so 
prescriptions could be reviewed with the 
patient because the risk–benefit was quite 
balanced.’ (GP 1, England)
Practice-level quality improvement 
actions. Flags were added to the notes of 
all patients with heart failure suggesting 
the avoidance of NSAIDs and glitazones; 
all clinicians within participating practices 
were made aware of the identified issues 
with prescribing and patient safety:
‘[We] have flagged up NSAIDs on relevant 
notes — and have been changing practice 
as a result.’ (GP 2, Scotland)
Appraisal and revalidation. One participant 
described how they had used their QI report 
to review and alter the care of relevant 
patients within their practice. They then 
reported this as evidence for their annual 
appraisal and revalidation with the General 
Medical Council (Domain 2 — Safety and 
Quality).
Box 3. Criteria used for the selection of indicators to be included in the 
pilot QI reports
•  The prescribing safety indicators are rated by risk of harm to the patient and only indicators rated 4 
(extreme risk of harm) or 3 (high risk of harm) were considered for inclusion.
•  CPRD researchers reviewed the subset of indicators thus shortlisted to identify which ones were likely to 
be recorded well in the CPRD primary care data.
•  Initial searches were conducted in the CPRD data to ascertain the number of patients that would be 
identified for the indicators under consideration; indicators affecting the highest number of affected 
patients were prioritised.
•  Indicators needed to identify safety events that were common enough to report on for most practices, but 
not so common as to make patient review unmanageable for GP workload.
•  The MHRA was consulted to ensure that the QI reports did not include any prescribing indicators for drugs 
that were being actively monitored as part of the MHRA Patient Safety Alert effectiveness monitoring to 
avoid biasing their findings.
CPRD = Clinical Practice Research Datalink. MHRA = Medicines and Healthcare products Regulatory Agency. 





































Average across all practices
Figure 2. Benchmarking of practice prescribing 
rates (hypothetical data).
HF = heart failure. NSAIDs = non-steroidal anti-
inflammatory drugs. QOF = Quality and Outcomes
Framework.
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No further amendments were made to 
the design of the report in response to 
interviews conducted as part of the 
implementation phase. 
Scale-up phase
Reports were sent to 291 CPRD Vision 
practices in July 2017 covering prescriptions 
in the previous financial year. Updated 
reports were sent to 271 Vision and 186 
EMIS practices in December 2017 covering 
the subsequent 6-month period.
DISCUSSION
Summary
This pilot study demonstrates how routine 
EHRs can be used to implement a QI 
initiative that has the capacity to directly 
impact patient care. The production and 
dissemination of reports was automated 
to enable UK-wide scalability and 
sustainability over time, thus allowing GPs 
to observe change in their practice. The 
involvement of GPs in the design phase 
ensured that the reports were acceptable 
and clinically meaningful. Unlike the 
schemes identified in the scoping review 
and wider literature, the RCGP/CPRD QI 
reports provide patient-level feedback, allow 
re-identification of patients for case-finding, 
enable comparison with peers nationally, 
do not require GPs to implement their own 
searches, and are free of charge.
Strengths and limitations
QI initiatives, clinical audits, and learning 
event analysis are longstanding within 
primary care, but are often unsustainable 
due to a high administrative burden14,15 
and many initiatives may never reach the 
scientific literature. The review exercise 
highlighted that many of the resources 
currently used by GPs for QI are not 
produced primarily for that purpose and 
are often limited to aggregate data at 
practice-level or larger geographies. The 
authors’ use of patient-level EHR data that 
are collected daily from general practices 
enables production of timely, standardised 
QI reports enabling both benchmarking and 
individual case-finding. 
The structure of CPRD data is a strength, 
allowing queries to be reproduced at 
regular intervals as demonstrated in the 
pilot study. The reports were scaled up 
to cover a larger number of GP practices 
across two GP software systems. This is 
made possible by automation of production, 
including publication of the reports and their 
dissemination to recipients via email. The 
reports used in this study have the potential 
to facilitate a continuous and sustainable 
approach to QI, which is consistent across 
GP practices that contribute data to CPRD. 
A potential limitation of using de-identified 
EHR data that do not contain details such as 
names or NHS numbers is that individual 
case-finding is usually not possible. For 
this initiative, case-finding was made 
possible by providing the practices with 
pseudonymised identifiers, which could be 
used by GPs to re-identify their own patients 
via entry into the individual practice’s 
computer system. This ensured patient 
confidentiality while reducing the burden 
on practice staff reviewing the highlighted 
patients. However, these data governance 
considerations mean that these reports 
can only be generated in collaboration with 
CPRD. 
Another potential limitation is that the 
reports rely on the validity of EHR data for 
accurate identification of patients triggering 
the indicators. Recording of primary care 
data may be impacted by different factors 
including practice characteristics, pay for 
performance and QI schemes such as 
QOF, and differences in practice software 
systems.16 The validity of diagnoses in 
CPRD have been investigated with generally 
positive findings.17 However, expert clinical 
input when designing case definitions 
in any EHR data is always advisable and 
was sought during the development of 
the indicators in this pilot. The pilot study 
focused on a condition (heart failure) that 
has been included in QOF since its onset 
in 2004. Nevertheless, to overcome any 
potential misclassification issues, the 
From the 7438 patients registered at your practice on the data extraction date, we found:
• 118 patients with heart failure based on the QOF definition
 – 3 of these patients had a record of at least one dispensing of an NSAID between June
 and November 2017; these patients are:
Substance
• 98 additional patients with heart failure based on the broad definition
 – 2 of these patients did not meet the QOF criteria and had a record of at least one










naproxen 500 mg tablets
naproxen 500 mg tablets








naproxen 250 mg gastro-resistant tablets
naproxen 500 mg tablets
Figure 3. Case-finding table (hypothetical data). 
NSAIDs = non-steroidal anti-inflammatory drugs. 
QOF = Quality and Outcomes Framework.
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researchers used two code lists to identify 
patients, one based on QOF, and the 
second based on a broader definition that 
would prioritise sensitivity over specificity. 
The recording of non-QOF conditions will 
need to be considered in the development 
of future indicators and clinical input 
sought to ensure that the indicators are 
implemented in a clinically meaningful way 
using EHR data.18,19 Partnership with the 
RCGP offered a high degree of clinical input 
into development of the indicators, and the 
study drew on RCGP expertise in quality 
improvement and patient safety.20 During 
the pilot study there were poor response 
rates to the second questionnaire and GP 
interview components. The authors have 
not been able to explore the reasons for 
this, but research of this nature requires 
a pragmatic approach and they used the 
feedback obtained to tailor the reports. 
Comparison with existing literature
Since the inception of this project other 
similar initiatives have been trialled and 
evaluated. In Scotland, the Data-driven 
Quality Improvement in Primary Care 
(DQIP) study21,22 and Effective Feedback to 
Improve Primary Care Prescribing Safety 
(EFIPPS) trial11 used similar techniques to 
provide practices with benchmarking data 
and search tools for case identification. 
These studies incorporated more intensive 
interventions than the present project but 
were based on one-off interventions over 
a period of 1 year and acknowledged the 
importance of repeatability for sustained 
effect and of scalability for large-scale 
implementation, both of which the RCGP/
CPRD QI reports allow with minimal 
additional resource.
The pharmacist-led information 
technology intervention for medication 
errors (PINCER) comprised a pharmacist-
led intervention in combination with 
patient-level prescribing feedback to reduce 
inappropriate prescribing in primary care. 
This cluster randomised controlled trial 
demonstrated a reduction in hazardous 
prescribing for the intervention arm over 
the control arm of feedback alone, which 
could be considered similar to the current 
study.9 The PINCER intervention has 
been successfully scaled up in the East 
Midlands since the trial, and is planned 
for national roll-out by NHS England. 
The PINCER tool interfaces directly with 
the practice’s system and allows staff to 
interrogate the data to identify patients at 
risk. At the time of writing this article, a 
small annual licence fee was required for 
access to the tool.23 By contrast, the RCGP/
CPRD QI tool is produced externally, with 
pdf reports emailed to practices free of 
charge as per the expressed preference 
of GPs participating in the present pilot. 
Benchmarking in the reports is against all 
practices in the CPRD network across the 
UK. 
Implications for practice
CPRD has incorporated the RCGP/CPRD 
reports into business-as-usual activities 
as part of its GP engagement strategy 
with the aim of sending out two to four 
reports per year, with new indicators added 
each year. The next research output from 
this project will be an impact evaluation 
to determine whether the reports have 
resulted in changes to prescribing for the 
relevant indicators.
System-level changes, such as the 
migration to Systematized Nomenclature 
of Medicine Clinical Terms (SNOMED 
CT) coding and associated Read code 
retirement in primary care from 2018 and 
the move away from QOF in Scotland, will 
need to be considered when developing 
future indicators to ensure comparability 
over time. Including a range of code lists 
alongside the original ones will allow 
benchmarking over time in a clinically 
meaningful way.24 Code lists used in the 
reports are available to GPs receiving the 
report and can be obtained on request. 
The NHS England clinical pharmacist 
pilot scheme is now complete and is due 
to be extended nationally, providing an 
additional 2000 pharmacists in general 
practice by 2020.4,25 The RCGP/CPRD QI 
reports could prove a valuable tool alongside 
the clinical pharmacist scheme in initiating 
relevant QI actions within the practices that 
receive them.
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